T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
Gutierrez M, Bladek P, Goksu B, Murga-Zamalloa C, Bixby D, Wilcox R.
Int J Mol Sci. 2023 Jul 28;24(15):12106. doi: 10.3390/ijms241512106.
PMID:37569479
T-cell Prolymphocytic Leukemia.
Sud A, Dearden C.
Hematol Oncol Clin North Am. 2017 Apr;31(2):273-283. doi: 10.1016/j.hoc.2016.11.010.
PMID:28340878
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
Staber PB, Herling M, Bellido M, Jacobsen ED, Davids MS, Kadia TM, Shustov A, Tournilhac O, Bachy E, Zaja F, Porkka K, Hoermann G, Simonitsch-Klupp I, Haferlach C, Kubicek S, Mayerhoefer ME, Hopfinger G, Jaeger U, Dearden C.
Blood. 2019 Oct 3;134(14):1132-1143. doi: 10.1182/blood.2019000402. Epub 2019 Jul 10.
PMID:31292114
T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches.
Colon Ramos A, Tarekegn K, Aujla A, Garcia de de Jesus K, Gupta S.
Cureus. 2021 Feb 9;13(2):e13237. doi: 10.7759/cureus.13237.
PMID:33728186
T-cell prolymphocytic leukemia: Review of an entity and its differential diagnostic considerations.
Frater JL.
Int J Lab Hematol. 2020 Jun;42 Suppl 1:90-98. doi: 10.1111/ijlh.13180.
PMID:32543075
T-cell prolymphocytic leukemia, a case report and review of the literature.
GONZáLEZ-RODRíGUEZ LM, JUáREZ-Salcedo LM, Loscertales J, Arranz E, Cannata-Ortiz J, Ortiz J, LA Osa MJL, Alegre A, Dalia S.
Oncol Res. 2025 Feb 28;33(3):505-517. doi: 10.32604/or.2025.058175. eCollection 2025.
Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan.
Yamaguchi M, Fukuhara N, Takizawa J, Ishitsuka K, Yokohama A, Miyazaki K, Nato Y, Ichikawa S, Mitobe M, Shima K, Miyazawa Y, Izutsu K, Suzuki R, Nagai H, Nakamura N.